Director

Michael F. Roman

Director·Abbott Laboratories

About

Michael F. Roman served as Executive Chairman of the Board of 3M Company from May 2024 to March 2025 and as Chairman of the Board, President and Chief Executive Officer of 3M from 2019 to 2024. He held numerous leadership roles at 3M including Chief Operating Officer and Executive Vice President from 2017 to 2018. He joined Abbott's Board of Directors in 2021.

Since 2021
Age 66
Tenure 5 yrs

Also at Abbott Laboratories

NM Nita Ahuja, M.D. Director RM Robert J. Alpern, M.D. Director CB Claire Babineaux-Fontenot Director SP Sally E. Blount, Ph.D. Director RF Robert B. Ford Chairman of the Board and Chief Executive Officer; Director PG Paola Gonzalez Director

Roles

Organization Role Dates Details
Abbott Laboratories Director 2021–present Current role
3M Company Executive Chairman of the Board May 2024 to March 2025 A global manufacturing and technology company.
3M Company Chairman of the Board, President and Chief Executive Officer 2019 to 2024
3M Company Chief Executive Officer 2018 to 2019
3M Company Chief Operating Officer and Executive Vice President 2017 to 2018 With direct responsibilities for 3M's five business groups and its international operations.
3M Company Executive Vice President, Industrial Business Group 2014 to 2017
3M Company Senior Vice President, Business Development 2013 to 2014
3M Company Vice President and General Manager of Industrial Adhesives and Tapes Division 2011 to 2013

External roles

Organization Role Dates
Waystar Holding Corp. Board of Directors member

Related

Company Abbott Laboratories Company hub Person Nita Ahuja, M.D. Director Person Robert J. Alpern, M.D. Director Person Claire Babineaux-Fontenot Director Person Sally E. Blount, Ph.D. Director Person Robert B. Ford Chairman of the Board and Chief Executive Officer; Director Person Paola Gonzalez Director Person Michelle A. Kumbier Director Person Darren W. McDew Director Person Nancy McKinstry Lead Independent Director Person Michael G. O'Grady Director Person Daniel J. Starks Director Person John G. Stratton Director Deal Abbott Laboratories Advanced Medical Optics 2009 Deal page Deal Abbott Laboratories Alere 2017 Deal page Deal Abbott Laboratories Basf S Pharmaceutical Business Knoll 2001 Deal page
Source: Abbott Laboratories proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo